Novel Class of Small Molecules that inhibits Yellow Fever Virus replication

Yellow fever virus (YFV) is a mosquito-borne virus that causes an acute viral hemorrhagic disease in humans. The high morbidity, recurring large-scale outbreaks, vaccine shortages, and the absence of approved antiviral drugs continue to make YFV a major global health concern. Therefore, the development of safe and effective antiviral agents against YFV remains an urgent priority. In this study, we used a para-menthane monoterpenoid diol and various aldehydes to synthesize a broad series of heterocyclic compounds with hexahydro-2H-chromene and hexahydro-2H-4,6-(epoxymethane)chromene moieties. Evaluation of the antiviral activity of the synthesized compounds identified compound 8k bearing a the hexahydro-2H-4,6-(epoxymethano)chromene core as a potent novel inhibitor of YFV replication in vitro. Compound 8k significantly reduced extracellular viral RNA copies and infectious viral load, highlighting its potential as a promising lead for the development of novel anti-YFV therapeutics.

Authors

Institutions

Publication Details

Journal
ChemRxiv
Published
2026-11-12
DOI
https://doi.org/10.26434/chemrxiv.15012045/v1
Primary Topic
Mosquito-borne diseases and control
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Novel Class of Small Molecules that inhibits Yellow Fever Virus replication

И. В. Ильина, Suzanne J. F. Kaptein, Leen Delang, Konstantin Petrovich Volcho et al.
ChemRxiv
Mosquito-borne diseases and control
preprint

Novel Class of Small Molecules that inhibits Yellow Fever Virus replication

И. В. Ильина, Suzanne J. F. Kaptein, Leen Delang, Konstantin Petrovich Volcho, Rana Abdelnabi, Nariman Faridovich Salakhutdinov, Johan H. Neyts, Oksana S. Patrusheva, Shannan-Leigh Macleod, Joyce van Bree, Ahmed Mohammed
preprint en

Abstract

Yellow fever virus (YFV) is a mosquito-borne virus that causes an acute viral hemorrhagic disease in humans. The high morbidity, recurring large-scale outbreaks, vaccine shortages, and the absence of approved antiviral drugs continue to make YFV a major global health concern. Therefore, the development of safe and effective antiviral agents against YFV remains an urgent priority. In this study, we used a para-menthane monoterpenoid diol and various aldehydes to synthesize a broad series of heterocyclic compounds with hexahydro-2H-chromene and hexahydro-2H-4,6-(epoxymethane)chromene moieties. Evaluation of the antiviral activity of the synthesized compounds identified compound 8k bearing a the hexahydro-2H-4,6-(epoxymethano)chromene core as a potent novel inhibitor of YFV replication in vitro. Compound 8k significantly reduced extracellular viral RNA copies and infectious viral load, highlighting its potential as a promising lead for the development of novel anti-YFV therapeutics.

ChemRxiv
Rega Institute for Medical Research (BE), Novosibirsk Institute of Organic Chemistry (RU)
Siberian Branch, Russian Academy of Sciences, Ministry of Science and Higher Education of the Russian Federation
Good health and well-being
Mosquito-borne diseases and control
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon